Table 2.
+ DHT | ||||
Clinical PCOS trait | WT mouse | Global loss of AR | Neuronal loss of AR | Granulosa cell loss of AR |
Absent/irregular cycling | ✓ | ✗ | ✓ | Partial |
Oligo/anovulation | ✓ | ✗ | ✗ | ✓ |
Classic multicystic ovarian appearance | ✓ | ✗ | Partial | ✓ |
Change in ovary weight* | ✓ | ✗ | ✓ | ✓ |
↑Unhealthy small antral follicles | ✓ | ✗ | ✓ | ✓ |
↑Unhealthy large antral follicles | ✓ | ✗ | ✗ | ✓ |
↓Granulosa cell-layer thickness | ✓ | ✗ | ✓ | ✗ |
↑Theca cell-layer thickness | ✓ | ✗ | ✓ | ✓ |
↑Body weight | ✓ | ✗ | ✗ | ✓ |
↑Parametrial fat-pad weight | ✓ | ✗ | ✗ | ✓ |
↑Retroperitoneal fat-pad weight | ✓ | ✗ | ✗ | ✓ |
↑Inguinal fat-pad weight | ✓ | ✗ | ✗ | ✓ |
↑Mesenteric fat-pad weight | ✓ | ✗ | ✗ | ✓ |
Adipocyte hypertrophy | ✓ | ✗ | Partial | ✓ |
↓Adiponectin | ✓ | ✗ | ✓ | ✓ |
Dyslipidemia† | ✓ | ✗ | ✗ | ✓ |
Hepatic steatosis | ✓ | ✗ | Partial | ✓ |
Impaired fasting glucose | ✓ | ✗ | ✓ | ✓ |
✓, clinical PCOS trait present; ✗, clinical PCOS trait not present; partial, effect of DHT evident but not to the same extent seen in WT mice.
↑ In humans; ↓ in mice.
↑Cholesterol + clear trend toward ↑triglycerides.